Duloxetine (Compound)

Synonyms:duloxetine, 116539-59-4, (S)-Duloxetine, Cymbalta, Yentreve, (S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine, LY 248686, UNII-O5TNM5N07U, Ariclaim, Xeristar, Yentreve (TN), methyl[(3S)-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amine, O5TNM5N07U, 2-Thiophenepropanamine, N-methyl-gamma-(1-naphthalenyloxy)-, (gammaS)-, LY248686, CHEBI:36795, (3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine, (3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine, MFCD06801358, LY-248686, N-Methyl-gama-(1-naphthalenyloxy)-2-thiophenepropanamine, (3s)-N-Methyl-3-(Naphthalen-1-Yloxy)-3-(Thiophen-2-Yl)propan-1-Amine, Duloxetine [INN:BAN], Duloxetine (INN), SMR000449282, HSDB 7368, NCGC00164559-01, Duloxetine Boehringer Ingelheim, (S)-N-Methyl-gamma-(1-naphthalenyloxy)-2-thiophenepropanamine, 29E, CPD000449282, SCHEMBL8291, CHEMBL1175, GTPL202, MLS000758267, MLS001423946, (S)-Duloxetine;LY248686, DTXSID6048385, BDBM84745, HMS2051I05, HMS3886K11, HY-B0161, ZINC1536779, (3S)-N-methyl-3-(naphthalen-1-yloxy)-3-(2-thienyl)propan-1-amine, 2-Thiophenepropanamine, N-methyl-gamma-(1-naphthalenyloxy)-, (S)-, PDSP1_000969, PDSP1_001385, PDSP2_000953, PDSP2_001369, s5071, AKOS015851058, CCG-100763, CM14423, DB00476, NC00013, VA11973, NCGC00164559-02, NCGC00164559-04, AC-15704, AS-35259, SBI-0206832.P001, CAS_136434-34-9, D07880, AB00639911-13, AB00639911_15, AB00639911_16, 539D594, Q411932, J-003455, J-523680, (+)-(S)-N-Methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamin, (S)-(+)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine, (S)-N-methyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamine, (3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-yl-propan-1 amine, (3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-yl-propan-1-amine, (3s)-n-methyl-3-naphthalen-1-yloxy-3-thiophen-2-yl-propan-1amine, (S)-(+)-N-methyl-3-(1-naphthaleneoxy)-3-(2-thienyl)propanamine

Pubchem:PUBCHEM:60835

Id:60835

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Duloxetine's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Duloxetine.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Duloxetine.

Results found

Linked to

	Label	Description
	BRD-K71103788-003-11-2 Substance (Entity type)	A Substance
	DCSTRUCT ID 00972 Collection (Entity type)	DrugPage Collection: (DrugCentralID:00972; PubChem_CID:60835, FILE=drugcentral_drug_00972.json)
	duloxetine (ef487875-6ae6-47fb-a359-1030bbb855fb) Collection (Entity type)	Metadatata for duloxetine
	Duloxetine bioactivity Potassium voltage-gated channel subfamily H member 2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Duloxetine in similarity relationship with dorzolamide Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Duloxetine negatively regulates LGALS3BP Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Duloxetine positively regulates LMO2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Duloxetine negatively regulates GUSBP3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Duloxetine positively regulates PCDH9 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Duloxetine negatively regulates RPS4Y1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS